A compound of Formula (I): ** Formula ** or a pharmaceutically acceptable salt thereof, wherein: Q is ** Formula ** R1 is: (i) C3-6 alkyl； (ii) C3-7 cycloalkyl substituted with zero to 3 substituents independently selected from halogen, - CN, C1-4 alkyl, C1-4 alkoxy, C1-3 fluoroalkyl, C1-3 chloroalkyl and / or C1-2 fluoroalkoxy； (iii) phenyl substituted with zero to 3 substituents independently selected from halogen, -CN, C1-4 alkyl, C3-6 cycloalkyl, C1-4 alkoxy, C1-3 fluoroalkyl, C1-3 chloroalkyl and / or C1-2 fluoroalkoxy ； or (iv) pyridinyl substituted with zero to 3 substituents independently selected from halogen, -CN, C1-4 alkyl, C3-6 cycloalkyl, C1-4 alkoxy, C1-3 fluoroalkyl, C1-3 chloroalkyl and / or C1- fluoroalkoxy 2； R2 is CF3； n is zero, 1, or 2； each R3 is independently C1-3 alkyl, F, Cl, C1-3 fluoroalkyl, C1-3 chloroalkyl, -CN, C1-3 alkoxy and / or C1-3 fluoroalkoxy； R4 is H or -CH3； R5 is H or -CH3； and G is: (i) H, C1-6 alkyl or C3-6 cycloalkyl； (ii) C1-6 alkyl substituted with -NH2, C1-6 alkoxy, -C (O) OH, -C (O) O (C1-6 alkyl) or -S (O) 2 C1-6 alkyl； (iii) C1-6 alkyl substituted with one or more substituents selected from -OH, -CN and / or cyclopropyl； (iv) - (CH2) 0-3-Ra, wherein Ra is C3-6 cycloalkyl substituted with zero to 2 substituents independently selected from -OH, -CN and / or -CH2OH； (v) - (CH2) 0-3-Rb, wherein Rb is phenyl substituted with zero to 2 substituents independently selected from -OH, C1-3 hydroxyalkyl and / or -S (O) 2NH2； (vi) - (CH2) 1-3C (O) NRcRd, wherein Rc is H or -CH3； and Rd is H, C1-6 alkyl, C3-6 cycloalkyl, C1-6 hydroxyalkyl, - (CH2) 0-2 (heteroaryl) or - (CH2) 0-2 (heterocyclyl)； (vii) -CH (CN) Re, wherein Re is phenyl, benzyl, -C (O) NH2 or -C (O) NH (C1-3 alkyl)； (viii) -CHRfC (O) NH (CH3), wherein Rf is C1-6 alkyl, -CN, phenyl, benzyl or -CH2CH2-phenyl； (ix) - (CH2) 1-3NHC (O) Rg, wherein Rg is C1-6 alkyl or -O (C1-6 alkyl)； (x) -CHRh- (CH2) 0-3-Ri, wherein Rh is H or -CH3 and Ri is heteroaryl； (xi) - (CH2) 0-3-
